Results 181 to 190 of about 26,367 (213)

Cocaine-Induced Changes in the BRD4 Interactome Identifies Casein Kinase 1 Epsilon as a Therapeutic Target. [PDF]

J Neurochem
Seyednejad A, Sacko TJ, Babigian CJ, Moore TE, Xiao S, Liddle JC, Sartor GC.   +6 more
europepmc   +1 more source

Direct Readout of Multivalent Chromatin Reader-Nucleosome Interactions by Nucleosome Mass Spectrometry. [PDF]

ACS Cent Sci
Lee AS, Fisher NP, Marunde MR, Su P, Khan LF, Ezell RJ, Gillespie ZB, Graham B, Taylor HF, Onuoha UC, Su T, Jooß K, Schachner LF, Fuchs HA, Noll K, Meiners MJ, Cheek MA, Burg JM, Sun ZW, Musselman CA, Keogh MC, Kelleher NL.   +21 more
europepmc   +1 more source

Development of cell-active BRD4-D1 selective inhibitors to decode the role of BET proteins in LPS-mediated liver inflammation. [PDF]

Eur J Med Chem
Scholtz CR, Doskey LC, Kandanur SGS, Vail NR, Roderick ER, Peterson EJ, Hoell ZJ, Shi K, Aihara H, Kostallari E, Shah VH, Malhi H, Pomerantz WCK.   +12 more
europepmc   +1 more source

BRD4 Empowers Macrophages to Fight Helicobacter pylori

Cellular and Molecular Gastroenterology and Hepatology
Hoft, Stella G., DiPaolo, Richard J.
openaire   +2 more sources

Molecular mechanism of RBM15-mediated m6A modification in hepatitis B virus replication. [PDF]

Virol J
Ni M, Li B, Wang L, Ma S, Ma K.
europepmc   +1 more source

Bromodomain and extra-terminal proteins in solid tumors: regulators of immune microenvironment and emerging therapeutic targets. [PDF]

Front Immunol
Sharma D, Bushnell GG, Kalman AP, Hutchens CM, Burness ML.   +4 more
europepmc   +1 more source

XQ2, a Novel Derivative of Resveratrol, Reactivates Latent HIV‑1 via the Activation of Positive Transcription Elongation Factor B. [PDF]

ACS Omega
Lai F, Zhou C, He H, Wu Z, Rashid HK, Chen P, Liu W, Liang T, Li C, Xi B, Li Y, Li L.   +11 more
europepmc   +1 more source

Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression. [PDF]

Cell Commun Signal
Kim JM, Nam AR, Oh KS, Bang JH, Jeong Y, Choo SY, Kim HJ, Lee SI, Yoon J, Kim TY, Oh DY.   +10 more
europepmc   +1 more source

PROTAC-based protein degradation: a window of opportunity for melanoma therapy. [PDF]

J Biomed Sci
Gentile G, D'Aguanno S, Di Martile M, Petricca A, Valentini E, Scalera S, Del Bufalo D.   +6 more
europepmc   +1 more source

Ginsenoside Rh2- functionalized liposomes enhanced BRD4-PROTAC delivery and antitumor efficacy <i>via</i> improved tumor targeting and ECM remodeling. [PDF]

Mater Today Bio
Wen L, Rao J, Chen J, Li F, Chen X, Guo S, Cui B, Qiu C, Chen W.   +8 more
europepmc   +1 more source